Heron Therapeutics | HRTX - Le Coût Des Ventes

Prix De L'Action
0.80
Variation Quotidienne
0.02 2.05%
Mensuellement
-27.06%
Annuel
-67.28%
Q1 Prévisions
0.76




Le Coût Des Ventes Changement Date
ALKERMES USD 46.21M 5.38M 2025-12
Alnylam Pharmaceuticals USD 267.72M 67.57M 2025-12
Amarin USD 26.05M 1.41M 2025-12
ANI Pharmaceuticals USD 122.88M 6.86M 2025-12
Anika Therapeutics USD 11.44M 797K 2025-12
Eisai JPY 51.08B 5.56B 2025-12
Emergent BioSolutions USD 381.2M 226.1M 2023-06
Esperion Therapeutics USD 27.85M 13.43M 2025-12
GlaxoSmithKline GBP 2.61B 377M 2025-12
Heron Therapeutics USD 11.12M 795K 2025-12
Insmed USD 46.16M 15.25M 2025-12
Ligand Pharmaceuticals USD 11.9M 733K 2025-09
Merck USD 3.32B 531M 2025-12
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Neurocrine Biosciences USD 17.6M 246.4M 2025-12
Omeros USD 33.16M 18.52M 2024-06
Pacira USD 54.62M 6.02M 2025-12
Regeneron Pharmaceuticals USD 584.6M 63M 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Sangamo BioSciences 2.42M 1.11M 2024-06
Surmodics USD 33.03M 24.58M 2024-09
Ultragenyx Pharmaceutical USD 29M 1.01M 2025-12
Veracyte USD 39.28M 1.93M 2025-12
Vertex Pharmaceuticals USD 466M 51.2M 2025-12